Calcium

The reviewed carbonate chewable relieves acid indigestion, heartburn and sour stomach. Selected gluconate / chloride injections treat acute symptomatic hypocalcemia in adults and pediatric patients; long-term injection safety (and chloride effectiveness) is unestablished. These labels do not establish a universal cardiac-arrest, hyperkalemia or toxicology protocol.

Calcium supports bone and normal physiological function. Supplementation addresses dietary shortfalls; adequate intake does not guarantee fracture prevention. Carbonate and citrate supplements differ from antacid and IV regimens. This overview does not endorse a branded citrate supplement, phosphate binder, vitamin-D combination or unreviewed emergency regimen.

Count food plus supplements. Adult daily requirements:1,000 mg at 19–50 years; at 51–70,men 1,000 mg and women 1,200 mg; over 70,1,200 mg. Pregnancy / lactation:1,000 mg adults,1,300 mg adolescents. Adult upper limits:2,500 mg at 19–50 and 2,000 mg after 50, not treatment targets. Divide supplement doses to≤500 mg elemental calcium per dose for absorption; carbonate with food, citrate less acid-dependent and usable without food.

Selected 100 mg / mL concentrate requires dilution in D 5 W or normal saline: bolus 10–50 mg / mL, no faster than 200 mg / minute adults or 100 mg / minute pediatric / neonates; continuous 5.8–10 mg / mL with rate adjusted to calcium. Use a secure IV line with ECG / vital-sign monitoring. Check calcium every 4–6 hours during intermittent or 1–4 hours continuous treatment. Renal impairment: start at the low end of each age range and check calcium every 4 hours. Do not equate neonatal dose group≤1 month with the ceftriaxone contraindication boundary≤28 days.

Selected chloride 100 mg / mL: adult 200–1,000 mg; pediatric 2.7–5 mg / kg, individualized to symptoms / ionized calcium. Renal starting doses: adult 200 mg, pediatric 2.7 mg / kg. The selected syringe cannot accurately supply doses<200 mg; use another suitable product for those doses. Infuse slowly in a central / deep vein, maximum 1 mL / minute (100 mg / minute); NO bolus, IM or subcutaneous administration. Repeat dosing requires reassessment; no fixed universal repeat interval is given.

Gluconate:hypercalcemia and neonates≤28 days receiving ceftriaxone. Chloride:ventricular fibrillation, asystole / electromechanical dissociation, and newborns≤28 days requiring or expected to require IV ceftriaxone even through different lines / times. Chloride hypercalcemia is a toxicity concern rather than identically listed in its formal§4. Do not turn these selected acute-hypocalcemia labels into an arrest protocol. Selected OTC Drug Facts lists prescription-drug consultation and duration warnings rather than an Rx-style contraindication list.

The selected antacid and both current injection labels have no boxed warning. Incompatibility, route and monitoring restrictions remain essential.

Oral supplements may cause gas, bloating or constipation. Injection reports include hypotension, arrhythmia, local inflammation / necrosis, calcinosis and extravasation. Chloride may cause burning, paresthesia, calcium taste or a heat-wave sensation. Hypercalcemia can cause weakness, confusion, GI symptoms and kidney effects. Reported frequencies cannot be reliably generalized across formulations.

The selected antacid advises doctor / pharmacist review with prescription medicines. Calcium can impair absorption of levothyroxine, quinolones or integrase inhibitors; follow the actual interacting medicine’s food / spacing instructions rather than a universal interval. Lithium can raise calcium. This profile supplies no unverified automatic spacing algorithm.

Both injections contraindicate neonatal≤28 day ceftriaxone co-use. In older patients, administer sequentially only with appropriate compatible-fluid line flushing / replacement; never mix or give simultaneously via Y-site. Chloride explicitly prohibits simultaneous administration even through different lines / sites. Gluconate also cannot be mixed with phosphate / bicarbonate fluids or minocycline injection. Chloride says not to mix simultaneously with other drugs. Pharmacy compatibility review is required.

Avoid IV calcium with cardiac glycosides / digoxin because arrhythmia risk rises; if necessary, selected labels require careful slow administration / ECG monitoring. Chloride additionally advises avoiding calcium-channel-blocker co-use or close BP monitoring if unavoidable; gluconate notes reduced blocker response. VitaminD / A, thiazides, estrogen, teriparatide and related agents can increase calcium; review all products and increase appropriate calcium monitoring.

Maternal hypocalcemia itself threatens mother / fetus. Gluconate pregnancy exposure data are insufficient to define risk; chloride labeling does not expect major adverse developmental outcomes with treatment of acute symptomatic hypocalcemia. Calcium is naturally in milk; gluconate’s IV effect on milk / infant is unknown, whereas chloride’s recommended approved dose is not expected to harm the infant. Assess maternal need and feeding context, not blanket all-product safety.

Both selected injections establish pediatric acute-symptomatic-hypocalcemia treatment, with neonatal ceftriaxone / aluminum restrictions. The chloride syringe’s<200 mg limit still applies to weight-based pediatric dosing. Selected antacid self-use starts at 12; younger use requires a doctor. Older adults need cautious IV selection and review of renal function, medicines and total intake.

Renal impairment requires low-end injection starts and closer calcium / phosphorus monitoring, not a generic oral or dialysis dose. Gluconate says hepatic adjustment may be unnecessary because release of ionized calcium does not require liver metabolism; chloride organ-specific PK effects have not been evaluated. CKD / phosphate-binder / stone-prevention regimens require disease-specific review and are excluded.

Carbonate antacid neutralizes stomach acid. IV gluconate / chloride dissociate and increase serum ionized calcium. Calcium is mainly stored in the skeleton and supports normal signaling and muscular function; nutrition and pharmacologic correction are separate purposes.

IV administration is fully bioavailable; calcium itself is not directly metabolized. Serum calcium includes ionized, protein-bound and complexed fractions; kidney filtration / reabsorption influences elimination. A standard drug half-life is not provided for choosing replacement intervals. Oral absorption varies with formulation, dose and gastric conditions; do not calculate an IV replacement dose from an oral supplement.

For acute IV correction assess ionized / serum calcium, symptoms, renal function, phosphorus risk, ECG / vitals and access site; use the selected gluconate calcium intervals above and chloride frequency based on renal risk. Review digoxin and ceftriaxone. For oral products review total intake, prescription interactions and persistent heartburn; calcium checks depend on clinical risks rather than a universal nutritional blood-test schedule.

Chew the selected antacid and respect its 8 tablet / day and 2 week limits. Read elemental-calcium and serving-size information on supplements; check duplicate calcium / vitaminD products. Report worsening weakness, confusion, vomiting, palpitations or reduced urine. IV calcium is for professional administration; report pain / burning immediately. No home injection, salt conversion or feeding-tube recipe is supplied.

Seek medical / Poison Control help for excessive intake or significant symptoms. IV overdose requires promptly stopping administration and clinical reassessment / supportive management of hypercalcemia. Do not wait for a numeric serum threshold or attempt a home antidote / forced fluid protocol. Wrong concentration, route or unit is an urgent medication error.

Product

Amneal calcium gluconate 100 mg / mL concentrate

Route

IV after required dilution; prescription

Appearance

Sterile clear colorless / slightly yellow solution

Example package

10 mL single-dose vial · NDC 80830-1672-1

Selected carbonate chewable 500 mg supplies 200 mg elemental calcium. Selected gluconate 100 mg / mL supplies 9.3 mg (0.465 mEq) elemental calcium / mL;10 / 50 mL single-dose vials and 100 mL pharmacy bulk package. Selected chloride 10% (100 mg / mL) supplies 27 mg or 1.4 mEq elemental calcium / mL in 10 mL Ansyr syringe, NDC 0409-1631-10 bundle 10. Citrate supplements must use their own Supplement Facts / serving size; no branded citrate identification or interchangeable dose is asserted.

Selected antacid:room temperature per Drug Facts. Gluconate:20–25°C, do not freeze; use diluted solution immediately, discard single-dose remainder, finish pharmacy-bulk dispensing within 4 hours in an appropriate ISO 5 area and use each dose immediately. Gluconate label permits controlled warming to 60–80°C with agitation to dissolve precipitate, cooling to room temperature and use only if clear; this is professional product handling, not permission to infuse visible particles. Chloride:20–25°C, excursions 15–30°C; inspect seal / clarity and discard remainder. No universal supplement storage / opened-liquid expiry is invented.